First At-Home Screening Test for Amniotic Fluid Leakage During Pregnancy Now Available.

MONTVALE, N.J. -- AmniScreen[TM] (NYSE:BRL) is the first and only FDA-approved at-home screening test for amniotic fluid leakage during pregnancy, a condition that may lead to serious complications such as infection and preterm labor. AmniScreen[TM] is now available by prescription only and can be purchased in retail pharmacies. AmniScreen[TM] is a panty liner test that offers the convenience of at-home screening for pregnant women who experience unexplained vaginal wetness. One AmniScreen[TM] test kit contains three panty liners and three drying trays, offering screening just about anytime, anywhere.

"AmniScreen[TM] may offer reassurance to women concerned about unexplained vaginal wetness during pregnancy," says Nancy Jasper, MD, Assistant Clinical Professor, Department of OB/GYN, Columbia University, College of Physicians and Surgeons. "It's important to know when wetness may be caused by amniotic fluid leakage. This new tool provides pregnant women with an effective way to identify unexplained wetness, with easy-to-read results that should be discussed with their healthcare provider. This important new test is an additional resource which may provide healthcare providers with information to help determine the necessity of a patient hospital or office visit."

To read the entire release and view the video, click here: http://mnr.onthescene.com/Amni/screen.html

B Roll Hard Copies Available Upon Request.